BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 25392217)

  • 1. A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease.
    Sarathy VV; White M; Li L; Gorder SR; Pyles RB; Campbell GA; Milligan GN; Bourne N; Barrett AD
    J Virol; 2015 Jan; 89(2):1254-66. PubMed ID: 25392217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of lethal dengue virus type 4 (DENV-4) TVP-376 infection in mice lacking both IFN-α/β and IFN-γ receptors (AG129) and comparison with the DENV-2 AG129 mouse model.
    Sarathy VV; Infante E; Li L; Campbell GA; Wang T; Paessler S; Robert Beatty P; Harris E; Milligan GN; Bourne N; Barrett ADT
    J Gen Virol; 2015 Oct; 96(10):3035-3048. PubMed ID: 26296350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lethal model of disseminated dengue virus type 1 infection in AG129 mice.
    Milligan GN; Sarathy VV; White MM; Greenberg MB; Campbell GA; Pyles RB; Barrett ADT; Bourne N
    J Gen Virol; 2017 Oct; 98(10):2507-2519. PubMed ID: 28949904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a murine model of non-lethal, symptomatic dengue virus infection.
    Sarathy VV; White M; Li L; Kaiser JA; Campbell GA; Milligan GN; Bourne N; Barrett ADT
    Sci Rep; 2018 Mar; 8(1):4900. PubMed ID: 29559699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice.
    Milligan GN; Sarathy VV; Infante E; Li L; Campbell GA; Beatty PR; Harris E; Barrett AD; Bourne N
    PLoS One; 2015; 10(5):e0125476. PubMed ID: 25938762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models of dengue virus infection for vaccine testing.
    Sarathy VV; Milligan GN; Bourne N; Barrett AD
    Vaccine; 2015 Dec; 33(50):7051-60. PubMed ID: 26478201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
    Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
    J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infant mouse brain passaged Dengue serotype 2 virus induces non-neurological disease with inflammatory spleen collapse in AG129 mice after splenic adaptation.
    Rajmane Y; Shaikh S; Basha K; Reddy GE; Nair S; Kamath S; Sreejesh G; Rao H; Ramana V; Kumar AS
    Virus Res; 2013 May; 173(2):386-97. PubMed ID: 23337909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice.
    Tan GK; Ng JK; Trasti SL; Schul W; Yip G; Alonso S
    PLoS Negl Trop Dis; 2010 Apr; 4(4):e672. PubMed ID: 20436920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.
    Züst R; Toh YX; Valdés I; Cerny D; Heinrich J; Hermida L; Marcos E; Guillén G; Kalinke U; Shi PY; Fink K
    J Virol; 2014 Jul; 88(13):7276-85. PubMed ID: 24741106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Systemic Infection with Dengue Virus Leads to Vascular Leakage and Death through Tumor Necrosis Factor-α and Tie2/Angiopoietin Signaling in Mice Lacking Type I and II Interferon Receptors.
    Phanthanawiboon S; Limkittikul K; Sakai Y; Takakura N; Saijo M; Kurosu T
    PLoS One; 2016; 11(2):e0148564. PubMed ID: 26844767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.
    Pinto AK; Brien JD; Lam CY; Johnson S; Chiang C; Hiscott J; Sarathy VV; Barrett AD; Shresta S; Diamond MS
    mBio; 2015 Sep; 6(5):e01316-15. PubMed ID: 26374123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine model for dengue virus-induced lethal disease with increased vascular permeability.
    Shresta S; Sharar KL; Prigozhin DM; Beatty PR; Harris E
    J Virol; 2006 Oct; 80(20):10208-17. PubMed ID: 17005698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence diversity of dengue virus type 2 in brain and thymus of infected interferon receptor ko mice: implications for dengue virulence.
    Dhole P; Nakayama EE; Saito A; Limkittikul K; Phanthanawiboon S; Shioda T; Kurosu T
    Virol J; 2016 Nov; 13(1):199. PubMed ID: 27903277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic characterization of patient dengue virus isolates in BALB/c mice differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome.
    Tuiskunen A; Wahlström M; Bergström J; Buchy P; Leparc-Goffart I; Lundkvist A
    Virol J; 2011 Aug; 8():398. PubMed ID: 21835036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice.
    Fuchs J; Chu H; O'Day P; Pyles R; Bourne N; Das SC; Milligan GN; Barrett AD; Partidos CD; Osorio JE
    Vaccine; 2014 Nov; 32(48):6537-43. PubMed ID: 25239488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue virus infects macrophages and dendritic cells in a mouse model of infection.
    Kyle JL; Beatty PR; Harris E
    J Infect Dis; 2007 Jun; 195(12):1808-17. PubMed ID: 17492597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models.
    Tang WW; Grewal R; Shresta S
    Curr Opin Virol; 2015 Aug; 13():61-6. PubMed ID: 26001278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity.
    Omatsu T; Moi ML; Hirayama T; Takasaki T; Nakamura S; Tajima S; Ito M; Yoshida T; Saito A; Katakai Y; Akari H; Kurane I
    J Gen Virol; 2011 Oct; 92(Pt 10):2272-2280. PubMed ID: 21697346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of activity testing for therapeutics against all four dengue virus serotypes in AG129 mouse models: Proof-of-concept studies with the adenosine nucleoside inhibitor NITD-008.
    Milligan GN; White M; Zavala D; Pyles RB; Sarathy VV; Barrett ADT; Bourne N
    Antiviral Res; 2018 Jun; 154():104-109. PubMed ID: 29665374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.